QM385 |
| Catalog No.GC37049 |
QM385 est un puissant inhibiteur de la sépiaptérine réductase (SPR) avec une IC50 de 1,49 nM, qui bloque la prolifération des lymphocytes T et l'auto-immunité À une puissance nanomolaire et avec une bonne biodisponibilité orale .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2296727-52-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
QM385 is a potent sepiapterin reductase (SPR) inhibitor with an IC50 of 1.49 nM, which blocks T-cell proliferation and autoimmunity at nanomolar potency and with good oral bioavailability[1]. IC50: 1.49 nM (Sepiapterin reductase)[1]
QM385 effectively inhibits the proliferation of human CD4+ T cells at low doses[1].
[1]. Cronin SJF, et al. The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. Nature. 2018 Nov;563(7732):564-568.
Average Rating: 5 (Based on Reviews and 18 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *